FIELD: medicine, pharmaceutics.
SUBSTANCE: what is described a new compound representing (2R)-5'-[5-(morpholin-4-ylmethyl)-3-furyl]-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine and a pharmaceutical composition binding with alpha-7 nicotinic receptors and containing them which can find application in medicine.
EFFECT: preparing the new pharmaceutical composition.
2 cl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
SPIROAZOBICYCLIC HETEROCYCLIC COMPOUNDS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2202553C2 |
FUROPYRIDINE ARALKYLAMINES, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE SUBSTANCES | 1999 |
|
RU2233282C2 |
NOVEL ESTERS OF QUATERNISED QUINUCLIDINE | 2005 |
|
RU2382041C2 |
(2S,3R-)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2,2,2]OCT-3-YL)BENZOFURANE-2-CARBOXAMIDE, NEW SALT FORMS AND METHODS FOR PREPARING THEM | 2008 |
|
RU2476220C2 |
DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS | 2003 |
|
RU2314306C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
AZABICYCLIC ALKANE DERIVATIVES SUBSTITUTED WITH CONDENSED BICYCLOHETEROCYCLE | 2007 |
|
RU2437884C2 |
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2687093C1 |
USE OF N-ARYLDIAZA SPIROCYCLIC COMPOUNDS FOR TREATING ADDICTIONS | 2005 |
|
RU2387647C9 |
Authors
Dates
2012-01-27—Published
2007-05-16—Filed